NCT02900235View on ClinicalTrials.gov

Mass Balance Study of MT-3995

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Healthy
Interventions
DRUG

MT-3995

Trial Locations (1)

Unknown

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY